Back Pain Doctor
MCL Injury
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
The MCL is the broad ligament on the inside of the knee. It is commonly injured when a force pushes the knee inward, although non-contact twisting can do the same. Examination grades tenderness and side-to-side laxity and checks the ACL, meniscus, patella and bone for associated injury.
Most isolated MCL injuries heal without surgery
Early care protects the ligament without unnecessarily immobilising the knee. Weight-bearing and movement are progressed as tolerated, with a hinged brace used selectively. Rehabilitation then restores full movement, quadriceps and hamstring strength, running, lateral movement and sport-specific contact or change of direction.
A 2024 systematic review of non-operative MCL rehabilitation found that immediate weight-bearing and ambulation as tolerated were commonly used for grade I and II injuries, while also highlighting that brace protocols and rehabilitation details remain inconsistent. That uncertainty is a reason to individualise the plan rather than apply one timeline to every sprain.
Combined ACL injury, a displaced ligament attachment, persistent valgus instability or a knee that is not progressing as expected changes the pathway. MRI and an orthopaedic opinion are arranged when they will affect management.
Common symptoms
- Pain and tenderness along the inside of the knee
- Swelling or bruising after contact or twisting
- Pain when changing direction or pushing sideways
- A feeling of side-to-side looseness or instability
Commonly seen in
Evidence for twelve treatment options in mcl injury
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation — diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.
What the evidence shows
Move it, within reason, rather than rest it. Pooling 22 studies, functional treatment beat immobilisation on return to sport, return to work, swelling, range of motion and patient satisfaction (Kerkhoffs, Arch Orthop Trauma Surg 2001). An overview of 46 systematic reviews found strong evidence for early mobilisation and moderate evidence for exercise (Doherty, Br J Sports Med 2016), and the international guideline prefers supervised exercise over passive modalities, reserving surgery for those who do not respond (Vuurberg, Br J Sports Med 2018). Exercise-based rehabilitation roughly halves the odds of doing it again within twelve months (Wagemans, PLoS One 2022). One honest caveat: in 503 patients with simple grade 1 to 2 ankle sprains, adding supervised physiotherapy to good advice produced no clinically important benefit (Brison, BMJ 2016).
Pairing reviewed 2026-09-02.
Where it fits for you
For a straightforward sprain or strain, clear advice and a graded return are usually enough, and you do not need to buy a course of anything. Supervised rehabilitation earns its place where the injury is more severe, where it keeps recurring, or where the demands you are returning to are high.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. No trials in this condition
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.
What the evidence shows
Searching the medial collateral ligament against dry needling, trigger point work and trigger point injection returned no treatment study at this ligament. The only medial-knee record is an observational mapping of tender points across 483 people with knee pain, in which 76 with medial-side diagnoses including collateral ligament injury had tender points on the medial knee and referred pain into the adductors and medial calf (Qin, Zhen Ci Yan Jiu 2020). There is no trial of needling for a medial collateral ligament injury, and nothing supports needling while the ligament is healing.
Pairing reviewed 2026-09-19.
Where it fits for you
Not used in the acute phase. Considered later only if a separate tender muscle band is still reproducing part of your pain.
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Only if relevant
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Ultrasound improves needle-placement accuracy, but guidance is not a treatment in itself: benefit depends on a valid injectable target and what is injected. Condition reviewed: MCL injury.
Evidence source: Oo et al., ultrasound-guided injection systematic review (2024)
Pairing reviewed 2026-08-30.
Where it fits for you
For MCL injury, an ultrasound-guided injection is considered only when there is a specific diagnostic question or a separate joint, bursa, sheath or nerve target. The injectate and purpose are stated before treatment.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible — no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits for you
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Only if relevant
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Shockwave reviews in myofascial pain report a possible benefit but mix protocols and often mix radial pressure wave with focused shockwave; that evidence cannot be transferred to the underlying diagnosis. Condition reviewed: MCL injury.
Evidence source: Wu et al., shockwave for myofascial pain review (2022)
Pairing reviewed 2026-08-30.
Where it fits for you
For MCL injury, radial pressure wave may be considered for a distinct superficial muscle or fascial component. It is not used as evidence of benefit for the primary diagnosis.
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Only if relevant
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
The shockwave evidence is in chronic, load-related problems. There is no established role in an acute injury.
Pairing reviewed 2026-08-30.
Where it fits for you
Not part of early management. May become relevant if the problem becomes chronic.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Plausible — no studies
What it involves
You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that we can point to. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative — a randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits for you
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why we describe it this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Plausible — no studies
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No randomised trial of PRP in MCL injury. The human evidence is uncontrolled: a series of 52 people with persistent pain after a low-grade MCL injury reported better IKDC scores after three weekly intra-articular PRP injections, but without a control group there is no way to separate the injection from time (Zou, J Int Med Res 2020), and beyond that there are three case reports (Yoshida, Clin J Sport Med 2019). The animal work disagrees with itself — PRP improved the structural properties of healing rabbit MCL (Yoshioka, Knee Surg Sports Traumatol Arthrosc 2013) but produced no difference in load to failure, stiffness or histology in rats (Amar, Arch Orthop Trauma Surg 2015).
Pairing reviewed 2026-09-02.
Where it fits for you
Most MCL injuries heal without an injection, so this rarely arises. If it does, it is only after a proper rehabilitation attempt has failed, and the absence of trial evidence is stated before any cost is discussed.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. One case report only
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No controlled trial of prolotherapy for a medial collateral ligament (MCL) injury was found. The only direct record is a single case: a rugby player with a grade 2 MCL sprain had 15% dextrose with lidocaine alongside exercise therapy and was pain-free with full movement at three weeks (Ada, Altern Ther Health Med 2015). One case cannot separate the injection from natural healing, which is usually good in this ligament. Rat studies of dextrose in the MCL are laboratory work and carry no weight here. PubMed search, 14 October 2026: prolotherapy, dextrose, hypertonic glucose or hyperosmolar with sprain, collateral ligament or ligament injury terms (21 records), and prolotherapy with ligament terms (121 records, all screened), each with randomised-trial and systematic-review passes.
Pairing reviewed 2026-10-14.
Where it fits for you
Most MCL sprains heal well with bracing where needed and rehabilitation. Prolotherapy can be discussed for an MCL that stays sore or lax months after a completed program, with the lack of trials stated.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Untested in people. A search pairing hyaluronic acid with the medial collateral ligament of the knee returned eight records and none treated an injured ligament. All eight were animal experiments, most of them cutting the ligament to bring on arthritis and then testing the injection on the joint cartilage (for example Kawano, Arthritis Rheum 2003). The only sprain in which hyaluronic acid has been trialled is the ankle (Petrella, Clin J Sport Med 2007). This is absence of evidence, not evidence that it fails.
Pairing reviewed 2026-10-05.
Where it fits for you
Not offered for this problem. Most MCL injuries heal without an injection, with graded loading and time.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Different injection target
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
The one dextrose report at this ligament injected the ligament, not the skin over it: a rugby player with a grade 2 medial collateral ligament sprain was given 15% dextrose with lignocaine alongside exercise and was pain free with full movement at three weeks, against a usual 4 to 8 weeks for conservative care of a complete tear (Ada, Altern Ther Health Med 2015). That is a single uncontrolled case of a different procedure, compared against a historical figure rather than a control group. Searching the perineural injection, neural prolotherapy, subcutaneous dextrose and glucopuncture terms against this ligament returns no study of small injections placed just under the skin.
Pairing reviewed 2026-09-28.
Where it fits for you
Not part of treating the ligament itself. Considered only if tender, hypersensitive skin over the inner knee persists once the sprain has otherwise settled.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: MCL injury.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits for you
For MCL injury, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments we do not offer, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.
When we would still consider it
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal — a trip, a procedure, a return to work
- Diagnostic use, where the response tells us where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other knee conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Does an MCL tear need surgery?
Will I need a brace?
Can the ACL be injured at the same time?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
Book an appointment